Absci ABSI
NASDAQ ABSI
$8.83 +0.03 (+0.34%)
As of: Sep 4, 2026 · 1:37 PM EDT

Absci (ABSI) Accumulated Expenses (2020 - 2025)

Absci (ABSI) posted Accumulated Expenses of $8.2 million for Q3 2025, up 43.99% sequentially from $5.7 million in Q2 2025, and down 54.9% YoY from $18.2 million in Q3 2024.

Analysis

Absci (ABSI) Accumulated Expenses (2020 - 2025) Analysis & Trends

Absci has reported Accumulated Expenses for 6 years, with the latest figure at $8.2 million in Q3 2025.

  • Quarterly Accumulated Expenses fell 54.9% year-over-year to $8.2 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $8.2 million (down 54.9% YoY) and the FY2024 annual result came in at $6.8 million, up 4.41% from the prior year.
  • Accumulated Expenses rose to $8.2 million in Q3 2025 per ABSI's latest filing, from $5.7 million in the prior quarter.
  • Over five years, Accumulated Expenses peaked at $25.6 million in Q1 2022 and troughed at $4.3 million in Q1 2025.
  • A 5-year average of $14.9 million and a median of $16.8 million in 2023 frame the typical range for Accumulated Expenses.
  • The sharpest annual moves came in 2021 and 2025: Accumulated Expenses jumped 1011.15% in 2021, then slumped 72.36% in 2025.
  • Over 5 years, Accumulated Expenses stood at $17.4 million in 2021, then gained by 17.48% to $20.5 million in 2022, then tumbled by 68.0% to $6.6 million in 2023, then increased by 4.41% to $6.8 million in 2024, then grew by 20.27% to $8.2 million in 2025.
  • According to Business Quant data, Accumulated Expenses over the past three periods registered $8.2 million, $5.7 million, and $4.3 million for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.31 Bn 131.46 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.65 Bn 77.66 Bn 3.93 Bn
3 Argenx Se 63.46 Bn 58.27 Bn 1.37 Bn
4 Moderna 57.94 Bn 52.80 Bn 52.00 Mn
5 Revolution Medicines 44.05 Bn 44.05 Bn -
6 BeOne Medicines 39.96 Bn 34.86 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.16 Bn 31.85 Bn 992.69 Mn
8 Royalty Pharma 28.44 Bn 27.60 Bn -
9 Insmed 27.32 Bn 26.16 Bn 358.27 Mn
10 Absci 1.39 Bn 1.19 Bn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 8.23 Mn
Jun 30, 2025 5.72 Mn
Mar 31, 2025 4.26 Mn
Dec 31, 2024 6.84 Mn
Sep 30, 2024 18.25 Mn
Jun 30, 2024 16.85 Mn
Mar 31, 2024 15.40 Mn
Dec 31, 2023 6.55 Mn
Sep 30, 2023 19.68 Mn
Jun 30, 2023 16.71 Mn
Mar 31, 2023 18.09 Mn
Dec 31, 2022 20.48 Mn
Sep 30, 2022 20.98 Mn
Jun 30, 2022 17.05 Mn
Mar 31, 2022 25.64 Mn
Dec 31, 2021 17.43 Mn
Sep 30, 2021 15.28 Mn
Jun 30, 2021 14.00 Mn
Dec 31, 2020 1.57 Mn